In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Director of Oculoplastics and Orbital Surgery, Yale University, discusses cosmeceuticals such as Latisse used for eyelash growth. Summary: Latisse…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Residency Program Director, Director of Oculoplastics and Orbital Surgery, Yale University, discusses orbital decompression for patients with thyroid eye…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Director of Oculoplastics and Orbital Surgery, Yale University, discusses referral of patients with thyroid eye disease. Summary: The three…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses artificial corneas or keratoprostheses and compares results to corneal transplantation using a human…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik surgery and long-term data showing prior lasik eye surgery affects measurements following…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of Ocular Oncology Section Yale University School of Medicine, describes uveal melanoma, a rare cancer but the most common cause…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses Barrett’s esophagus and its identification and treatment in the primary care…
NEW YORK (Reuters Health) – Liver transplant recipients whose indication for transplant was hepatitis C virus (HCV) cirrhosis have markedly poorer survival compared to patients transplanted for alcoholic…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor…
NEW YORK (Reuters Health) – Roughly 56% of melanomas detected in general dermatology practice are found through full-body skin examinations (FBSE), not as the result of patient complaint,…
